product-launch is the sole category represented across all 2 tracked stories. CapsoCam Plus is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. That works out to roughly 1.2 stories per week across a 12-day span.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Johnny Wang
product-launch is the sole category represented across all 2 tracked stories. CapsoCam Plus is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. That works out to roughly 1.2 stories per week across a 12-day span. Each story carries 2.5 original sources on average, compared with 2.1 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 5.9 for that window. We currently track 2 AI stories that mention Johnny Wang, published between August 3, 2026 and August 14, 2026.
Stories tracked
2
Per week
1.2
Sources per story
2.5
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 189 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Johnny Wang. Shared-story counts are live from our verified record — not editorial picks.
CapsoVision's Q2 shows scaling real-world deployment of capsule endoscopy with 176,000 patients imaged and AI software advancing for colon and upper GI. The 13% rise in capsule volume underscores growing data and workflow integration.
CapsoVision's AI Highlights leverages machine learning to automatically detect clinically relevant frames in small bowel capsule endoscopy videos, integrated with CapsoView and cloud review. The international launch, including the EU, highlights the growing role of AI in medical imaging.